Industry Research Reports

Home > Reports > Pharma & Healthcare > Medical Liquid Embolic Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Medical Liquid Embolic Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-12-21

Pages: 94 Pages

Report ld: 3407469

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Medical Liquid Embolic Agents was estimated to be worth US$ 133 million in 2023 and is forecast to a readjusted size of US$ 222 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030.

Medical liquid embolic agents are specialized substances used in interventional radiology to block blood flow in targeted blood vessels, typically for treating vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, or tumors. These agents are delivered via a catheter and solidify or precipitate upon contact with blood or tissue, creating a durable embolization effect. Common types include cyanoacrylate glues, ethylene-vinyl alcohol copolymer (EVOH), and onyx-based systems, which vary in composition, viscosity, and application methods. They offer a minimally invasive treatment option, reducing the need for open surgery while providing precise vascular occlusion to manage bleeding or cut off blood supply to abnormal tissues.

Medical Liquid Embolic Agents Market Size

M= millions and B=billions

North American market for Medical Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Medical Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Medical Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Medical Liquid Embolic Agents include Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Medical Liquid Embolic Agents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Liquid Embolic Agents by region & country, by Type, and by Application.

The Medical Liquid Embolic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Liquid Embolic Agents.

Market Segmentation

Report Metric
Details
Report Title
Medical Liquid Embolic Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 222 million
CAGR(2024-2030)
7.6%
Market Size Available for Years
2019-2030
Global Medical Liquid Embolic Agents Companies Covered
Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech
Global Medical Liquid Embolic Agents Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Liquid Embolic Agents Market, Segment by Type
EVOH-Based

Diluted Cyanoacrylate

Others
Global Medical Liquid Embolic Agents Market, Segment by Application
Brain Arterio-Venous Malformations (bAVM)

Tumor Embolization

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Liquid Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Medical Liquid Embolic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Medical Liquid Embolic Agents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Medical Liquid Embolic Agents Product Introduction
    1.2 Global Medical Liquid Embolic Agents Market Size Forecast
        1.2.1 Global Medical Liquid Embolic Agents Sales Value (2019-2030)
        1.2.2 Global Medical Liquid Embolic Agents Sales Volume (2019-2030)
        1.2.3 Global Medical Liquid Embolic Agents Sales Price (2019-2030)
    1.3 Medical Liquid Embolic Agents Market Trends & Drivers
        1.3.1 Medical Liquid Embolic Agents Industry Trends
        1.3.2 Medical Liquid Embolic Agents Market Drivers & Opportunity
        1.3.3 Medical Liquid Embolic Agents Market Challenges
        1.3.4 Medical Liquid Embolic Agents Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Medical Liquid Embolic Agents Players Revenue Ranking (2023)
    2.2 Global Medical Liquid Embolic Agents Revenue by Company (2019-2024)
    2.3 Global Medical Liquid Embolic Agents Players Sales Volume Ranking (2023)
    2.4 Global Medical Liquid Embolic Agents Sales Volume by Company Players (2019-2024)
    2.5 Global Medical Liquid Embolic Agents Average Price by Company (2019-2024)
    2.6 Key Manufacturers Medical Liquid Embolic Agents Manufacturing Base and Headquarters
    2.7 Key Manufacturers Medical Liquid Embolic Agents Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Medical Liquid Embolic Agents
    2.9 Medical Liquid Embolic Agents Market Competitive Analysis
        2.9.1 Medical Liquid Embolic Agents Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Medical Liquid Embolic Agents Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Liquid Embolic Agents as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 EVOH-Based
        3.1.2 Diluted Cyanoacrylate
        3.1.3 Others
    3.2 Global Medical Liquid Embolic Agents Sales Value by Type
        3.2.1 Global Medical Liquid Embolic Agents Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Medical Liquid Embolic Agents Sales Value, by Type (2019-2030)
        3.2.3 Global Medical Liquid Embolic Agents Sales Value, by Type (%) (2019-2030)
    3.3 Global Medical Liquid Embolic Agents Sales Volume by Type
        3.3.1 Global Medical Liquid Embolic Agents Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Medical Liquid Embolic Agents Sales Volume, by Type (2019-2030)
        3.3.3 Global Medical Liquid Embolic Agents Sales Volume, by Type (%) (2019-2030)
    3.4 Global Medical Liquid Embolic Agents Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Brain Arterio-Venous Malformations (bAVM)
        4.1.2 Tumor Embolization
        4.1.3 Others
    4.2 Global Medical Liquid Embolic Agents Sales Value by Application
        4.2.1 Global Medical Liquid Embolic Agents Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Medical Liquid Embolic Agents Sales Value, by Application (2019-2030)
        4.2.3 Global Medical Liquid Embolic Agents Sales Value, by Application (%) (2019-2030)
    4.3 Global Medical Liquid Embolic Agents Sales Volume by Application
        4.3.1 Global Medical Liquid Embolic Agents Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Medical Liquid Embolic Agents Sales Volume, by Application (2019-2030)
        4.3.3 Global Medical Liquid Embolic Agents Sales Volume, by Application (%) (2019-2030)
    4.4 Global Medical Liquid Embolic Agents Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Medical Liquid Embolic Agents Sales Value by Region
        5.1.1 Global Medical Liquid Embolic Agents Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Medical Liquid Embolic Agents Sales Value by Region (2019-2024)
        5.1.3 Global Medical Liquid Embolic Agents Sales Value by Region (2025-2030)
        5.1.4 Global Medical Liquid Embolic Agents Sales Value by Region (%), (2019-2030)
    5.2 Global Medical Liquid Embolic Agents Sales Volume by Region
        5.2.1 Global Medical Liquid Embolic Agents Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Medical Liquid Embolic Agents Sales Volume by Region (2019-2024)
        5.2.3 Global Medical Liquid Embolic Agents Sales Volume by Region (2025-2030)
        5.2.4 Global Medical Liquid Embolic Agents Sales Volume by Region (%), (2019-2030)
    5.3 Global Medical Liquid Embolic Agents Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Medical Liquid Embolic Agents Sales Value, 2019-2030
        5.4.2 North America Medical Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Medical Liquid Embolic Agents Sales Value, 2019-2030
        5.5.2 Europe Medical Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Medical Liquid Embolic Agents Sales Value, 2019-2030
        5.6.2 Asia Pacific Medical Liquid Embolic Agents Sales Value by Region (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Medical Liquid Embolic Agents Sales Value, 2019-2030
        5.7.2 South America Medical Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Medical Liquid Embolic Agents Sales Value, 2019-2030
        5.8.2 Middle East & Africa Medical Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Medical Liquid Embolic Agents Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Medical Liquid Embolic Agents Sales Value
        6.2.1 Key Countries/Regions Medical Liquid Embolic Agents Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Medical Liquid Embolic Agents Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Medical Liquid Embolic Agents Sales Value, 2019-2030
        6.3.2 United States Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Medical Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Medical Liquid Embolic Agents Sales Value, 2019-2030
        6.4.2 Europe Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Medical Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Medical Liquid Embolic Agents Sales Value, 2019-2030
        6.5.2 China Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Medical Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Medical Liquid Embolic Agents Sales Value, 2019-2030
        6.6.2 Japan Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Medical Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Medical Liquid Embolic Agents Sales Value, 2019-2030
        6.7.2 South Korea Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Medical Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Medical Liquid Embolic Agents Sales Value, 2019-2030
        6.8.2 Southeast Asia Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Medical Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Medical Liquid Embolic Agents Sales Value, 2019-2030
        6.9.2 India Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Medical Liquid Embolic Agents Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Medtronic
        7.1.1 Medtronic Company Information
        7.1.2 Medtronic Introduction and Business Overview
        7.1.3 Medtronic Medical Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
        7.1.4 Medtronic Medical Liquid Embolic Agents Product Offerings
        7.1.5 Medtronic Recent Development
    7.2 Balt Group
        7.2.1 Balt Group Company Information
        7.2.2 Balt Group Introduction and Business Overview
        7.2.3 Balt Group Medical Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
        7.2.4 Balt Group Medical Liquid Embolic Agents Product Offerings
        7.2.5 Balt Group Recent Development
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Company Information
        7.3.2 Johnson & Johnson Introduction and Business Overview
        7.3.3 Johnson & Johnson Medical Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
        7.3.4 Johnson & Johnson Medical Liquid Embolic Agents Product Offerings
        7.3.5 Johnson & Johnson Recent Development
    7.4 Meril Life
        7.4.1 Meril Life Company Information
        7.4.2 Meril Life Introduction and Business Overview
        7.4.3 Meril Life Medical Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
        7.4.4 Meril Life Medical Liquid Embolic Agents Product Offerings
        7.4.5 Meril Life Recent Development
    7.5 BlackSwan Vascular
        7.5.1 BlackSwan Vascular Company Information
        7.5.2 BlackSwan Vascular Introduction and Business Overview
        7.5.3 BlackSwan Vascular Medical Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
        7.5.4 BlackSwan Vascular Medical Liquid Embolic Agents Product Offerings
        7.5.5 BlackSwan Vascular Recent Development
    7.6 Success Bio-Tech
        7.6.1 Success Bio-Tech Company Information
        7.6.2 Success Bio-Tech Introduction and Business Overview
        7.6.3 Success Bio-Tech Medical Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
        7.6.4 Success Bio-Tech Medical Liquid Embolic Agents Product Offerings
        7.6.5 Success Bio-Tech Recent Development

 8 Industry Chain Analysis
    8.1 Medical Liquid Embolic Agents Industrial Chain
    8.2 Medical Liquid Embolic Agents Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Medical Liquid Embolic Agents Sales Model
        8.5.2 Sales Channel
        8.5.3 Medical Liquid Embolic Agents Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Medical Liquid Embolic Agents Market Trends
 Table 2. Medical Liquid Embolic Agents Market Drivers & Opportunity
 Table 3. Medical Liquid Embolic Agents Market Challenges
 Table 4. Medical Liquid Embolic Agents Market Restraints
 Table 5. Global Medical Liquid Embolic Agents Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global Medical Liquid Embolic Agents Revenue Market Share by Company (2019-2024)
 Table 7. Global Medical Liquid Embolic Agents Sales Volume by Company (2019-2024) & (K Dose)
 Table 8. Global Medical Liquid Embolic Agents Sales Volume Market Share by Company (2019-2024)
 Table 9. Global Market Medical Liquid Embolic Agents Price by Company (2019-2024) & (US$/Dose)
 Table 10. Key Manufacturers Medical Liquid Embolic Agents Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Medical Liquid Embolic Agents Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Medical Liquid Embolic Agents
 Table 13. Global Medical Liquid Embolic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Liquid Embolic Agents as of 2023)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medical Liquid Embolic Agents Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 17. Global Medical Liquid Embolic Agents Sales Value by Type (2019-2024) & (US$ Million)
 Table 18. Global Medical Liquid Embolic Agents Sales Value by Type (2025-2030) & (US$ Million)
 Table 19. Global Medical Liquid Embolic Agents Sales Market Share in Value by Type (2019-2024)
 Table 20. Global Medical Liquid Embolic Agents Sales Market Share in Value by Type (2025-2030)
 Table 21. Global Medical Liquid Embolic Agents Sales Volume by Type: 2019 VS 2023 VS 2030 (K Dose)
 Table 22. Global Medical Liquid Embolic Agents Sales Volume by Type (2019-2024) & (K Dose)
 Table 23. Global Medical Liquid Embolic Agents Sales Volume by Type (2025-2030) & (K Dose)
 Table 24. Global Medical Liquid Embolic Agents Sales Market Share in Volume by Type (2019-2024)
 Table 25. Global Medical Liquid Embolic Agents Sales Market Share in Volume by Type (2025-2030)
 Table 26. Global Medical Liquid Embolic Agents Price by Type (2019-2024) & (US$/Dose)
 Table 27. Global Medical Liquid Embolic Agents Price by Type (2025-2030) & (US$/Dose)
 Table 28. Global Medical Liquid Embolic Agents Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 29. Global Medical Liquid Embolic Agents Sales Value by Application (2019-2024) & (US$ Million)
 Table 30. Global Medical Liquid Embolic Agents Sales Value by Application (2025-2030) & (US$ Million)
 Table 31. Global Medical Liquid Embolic Agents Sales Market Share in Value by Application (2019-2024)
 Table 32. Global Medical Liquid Embolic Agents Sales Market Share in Value by Application (2025-2030)
 Table 33. Global Medical Liquid Embolic Agents Sales Volume by Application: 2019 VS 2023 VS 2030 (K Dose)
 Table 34. Global Medical Liquid Embolic Agents Sales Volume by Application (2019-2024) & (K Dose)
 Table 35. Global Medical Liquid Embolic Agents Sales Volume by Application (2025-2030) & (K Dose)
 Table 36. Global Medical Liquid Embolic Agents Sales Market Share in Volume by Application (2019-2024)
 Table 37. Global Medical Liquid Embolic Agents Sales Market Share in Volume by Application (2025-2030)
 Table 38. Global Medical Liquid Embolic Agents Price by Application (2019-2024) & (US$/Dose)
 Table 39. Global Medical Liquid Embolic Agents Price by Application (2025-2030) & (US$/Dose)
 Table 40. Global Medical Liquid Embolic Agents Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 41. Global Medical Liquid Embolic Agents Sales Value by Region (2019-2024) & (US$ Million)
 Table 42. Global Medical Liquid Embolic Agents Sales Value by Region (2025-2030) & (US$ Million)
 Table 43. Global Medical Liquid Embolic Agents Sales Value by Region (2019-2024) & (%)
 Table 44. Global Medical Liquid Embolic Agents Sales Value by Region (2025-2030) & (%)
 Table 45. Global Medical Liquid Embolic Agents Sales Volume by Region (K Dose): 2019 VS 2023 VS 2030
 Table 46. Global Medical Liquid Embolic Agents Sales Volume by Region (2019-2024) & (K Dose)
 Table 47. Global Medical Liquid Embolic Agents Sales Volume by Region (2025-2030) & (K Dose)
 Table 48. Global Medical Liquid Embolic Agents Sales Volume by Region (2019-2024) & (%)
 Table 49. Global Medical Liquid Embolic Agents Sales Volume by Region (2025-2030) & (%)
 Table 50. Global Medical Liquid Embolic Agents Average Price by Region (2019-2024) & (US$/Dose)
 Table 51. Global Medical Liquid Embolic Agents Average Price by Region (2025-2030) & (US$/Dose)
 Table 52. Key Countries/Regions Medical Liquid Embolic Agents Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 53. Key Countries/Regions Medical Liquid Embolic Agents Sales Value, (2019-2024) & (US$ Million)
 Table 54. Key Countries/Regions Medical Liquid Embolic Agents Sales Value, (2025-2030) & (US$ Million)
 Table 55. Key Countries/Regions Medical Liquid Embolic Agents Sales Volume, (2019-2024) & (K Dose)
 Table 56. Key Countries/Regions Medical Liquid Embolic Agents Sales Volume, (2025-2030) & (K Dose)
 Table 57. Medtronic Company Information
 Table 58. Medtronic Introduction and Business Overview
 Table 59. Medtronic Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 60. Medtronic Medical Liquid Embolic Agents Product Offerings
 Table 61. Medtronic Recent Development
 Table 62. Balt Group Company Information
 Table 63. Balt Group Introduction and Business Overview
 Table 64. Balt Group Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 65. Balt Group Medical Liquid Embolic Agents Product Offerings
 Table 66. Balt Group Recent Development
 Table 67. Johnson & Johnson Company Information
 Table 68. Johnson & Johnson Introduction and Business Overview
 Table 69. Johnson & Johnson Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 70. Johnson & Johnson Medical Liquid Embolic Agents Product Offerings
 Table 71. Johnson & Johnson Recent Development
 Table 72. Meril Life Company Information
 Table 73. Meril Life Introduction and Business Overview
 Table 74. Meril Life Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 75. Meril Life Medical Liquid Embolic Agents Product Offerings
 Table 76. Meril Life Recent Development
 Table 77. BlackSwan Vascular Company Information
 Table 78. BlackSwan Vascular Introduction and Business Overview
 Table 79. BlackSwan Vascular Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 80. BlackSwan Vascular Medical Liquid Embolic Agents Product Offerings
 Table 81. BlackSwan Vascular Recent Development
 Table 82. Success Bio-Tech Company Information
 Table 83. Success Bio-Tech Introduction and Business Overview
 Table 84. Success Bio-Tech Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 85. Success Bio-Tech Medical Liquid Embolic Agents Product Offerings
 Table 86. Success Bio-Tech Recent Development
 Table 87. Key Raw Materials Lists
 Table 88. Raw Materials Key Suppliers Lists
 Table 89. Medical Liquid Embolic Agents Downstream Customers
 Table 90. Medical Liquid Embolic Agents Distributors List
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources


List of Figures
 Figure 1. Medical Liquid Embolic Agents Product Picture
 Figure 2. Global Medical Liquid Embolic Agents Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Medical Liquid Embolic Agents Sales Value (2019-2030) & (US$ Million)
 Figure 4. Global Medical Liquid Embolic Agents Sales Volume (2019-2030) & (K Dose)
 Figure 5. Global Medical Liquid Embolic Agents Sales Price (2019-2030) & (US$/Dose)
 Figure 6. Medical Liquid Embolic Agents Report Years Considered
 Figure 7. Global Medical Liquid Embolic Agents Players Revenue Ranking (2023) & (US$ Million)
 Figure 8. Global Medical Liquid Embolic Agents Players Sales Volume Ranking (2023) & (US$ Million)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Liquid Embolic Agents Revenue in 2023
 Figure 10. Medical Liquid Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 11. EVOH-Based Picture
 Figure 12. Diluted Cyanoacrylate Picture
 Figure 13. Others Picture
 Figure 14. Global Medical Liquid Embolic Agents Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 15. Global Medical Liquid Embolic Agents Sales Value Market Share by Type, 2023 & 2030
 Figure 16. Global Medical Liquid Embolic Agents Sales Volume by Type (2019 VS 2023 VS 2030) & (K Dose)
 Figure 17. Global Medical Liquid Embolic Agents Sales Volume Market Share by Type, 2023 & 2030
 Figure 18. Global Medical Liquid Embolic Agents Price by Type (2019-2030) & (US$/Dose)
 Figure 19. Product Picture of Brain Arterio-Venous Malformations (bAVM)
 Figure 20. Product Picture of Tumor Embolization
 Figure 21. Product Picture of Others
 Figure 22. Global Medical Liquid Embolic Agents Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 23. Global Medical Liquid Embolic Agents Sales Value Market Share by Application, 2023 & 2030
 Figure 24. Global Medical Liquid Embolic Agents Sales Volume by Application (2019 VS 2023 VS 2030) & (K Dose)
 Figure 25. Global Medical Liquid Embolic Agents Sales Volume Market Share by Application, 2023 & 2030
 Figure 26. Global Medical Liquid Embolic Agents Price by Application (2019-2030) & (US$/Dose)
 Figure 27. North America Medical Liquid Embolic Agents Sales Value (2019-2030) & (US$ Million)
 Figure 28. North America Medical Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
 Figure 29. Europe Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 30. Europe Medical Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
 Figure 31. Asia Pacific Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Medical Liquid Embolic Agents Sales Value by Region (%), 2023 VS 2030
 Figure 33. South America Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 34. South America Medical Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
 Figure 35. Middle East & Africa Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 36. Middle East & Africa Medical Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
 Figure 37. Key Countries/Regions Medical Liquid Embolic Agents Sales Value (%), (2019-2030)
 Figure 38. Key Countries/Regions Medical Liquid Embolic Agents Sales Volume (%), (2019-2030)
 Figure 39. United States Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 40. United States Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
 Figure 41. United States Medical Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
 Figure 42. Europe Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 43. Europe Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
 Figure 44. Europe Medical Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
 Figure 45. China Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 46. China Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
 Figure 47. China Medical Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
 Figure 48. Japan Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 49. Japan Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
 Figure 50. Japan Medical Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
 Figure 51. South Korea Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 52. South Korea Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
 Figure 53. South Korea Medical Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
 Figure 54. Southeast Asia Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 55. Southeast Asia Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
 Figure 56. Southeast Asia Medical Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
 Figure 57. India Medical Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
 Figure 58. India Medical Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
 Figure 59. India Medical Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
 Figure 60. Medical Liquid Embolic Agents Industrial Chain
 Figure 61. Medical Liquid Embolic Agents Manufacturing Cost Structure
 Figure 62. Channels of Distribution (Direct Sales, and Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed

Description

The global market for Medical Liquid Embolic Agents was estimated to be worth US$ 133 million in 2023 and is forecast to a readjusted size of US$ 222 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030.

Medical liquid embolic agents are specialized substances used in interventional radiology to block blood flow in targeted blood vessels, typically for treating vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, or tumors. These agents are delivered via a catheter and solidify or precipitate upon contact with blood or tissue, creating a durable embolization effect. Common types include cyanoacrylate glues, ethylene-vinyl alcohol copolymer (EVOH), and onyx-based systems, which vary in composition, viscosity, and application methods. They offer a minimally invasive treatment option, reducing the need for open surgery while providing precise vascular occlusion to manage bleeding or cut off blood supply to abnormal tissues.

North American market for Medical Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Medical Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Medical Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Medical Liquid Embolic Agents include Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Medical Liquid Embolic Agents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Liquid Embolic Agents by region & country, by Type, and by Application.

The Medical Liquid Embolic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Liquid Embolic Agents.

Market Segmentation